MedPath

Study of comparison of endoscopic and surgical removal of large stones in bile duct

Phase 3
Recruiting
Conditions
Other specified diseases of biliary tract,
Registration Number
CTRI/2019/01/017055
Lead Sponsor
Department of Gastroenterology and Department of Surgery
Brief Summary

Gall bladder stones are associated with common bile duct (CBD) stones in 7-12% of patients. The preferred method of removal of bile duct stone is endoscopic retrograde cholangiopancreatography (ERCP). However the success rate of bile duct stone removal decreases with increase in size of stone especially ≥ 1.5 cm stones as well as the number of procedures. On the contrary laparoscopic CBD exploration (LCE) is a single stage procedure with the advantage of having cholecystectomy in same setting, but it is associated with complications such as bile leak, conversion to open surgery and prolonged hospitalization. It is not clear which is better for large CBD stone (≥ 1.5 cm). Our aim to compare both the modalities in patients with CBD stone of size 1.5 cm or more.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with a common bile duct stone of size 1.5 cm or more detected on a magnetic resonance cholangiopancreatography (MRCP) with or without gall stones, both pre and post cholecystectomy will be included in the study.

Exclusion Criteria

1.Presence of acute cholecystitis 2.Presence of acute cholangitis 3.Patients with obstructive jaundice with a serum bilirubin level higher than 10 mg/dl 4.Patients with a CBD diameter less than 10 mm 5.Patients with a history of hepatobiliary surgery other than cholecystectomy 6.Patient with uncorrectable coagulopathy 7.Patient with American Society Anaeathesiology (ASA) class 3 or more 8.Patient refusal to give consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be a composite of complete removal of stone in the bile duct by laproscopic CBD exploration (LCE) or endoscopic method, need of more than two attempts of ERCP for bile duct clearance or occurrence of major complication.at 1 month
Secondary Outcome Measures
NameTimeMethod
1. Complications of the intervention2. Procedure time in minutes

Trial Locations

Locations (1)

All India Institute of Medical Sciences

🇮🇳

South, DELHI, India

All India Institute of Medical Sciences
🇮🇳South, DELHI, India
Soumya Jagannath Mahapatra
Principal investigator
9990420767
soumyajagannath@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.